Orthofix Medical Inc.

Practice Area: 
Stock Symbol: 
Case Status: 

Ademi LLP is investigating possible securities fraud claims against Orthofix (NASDAQ: OFIX). The investigation results from inaccurate statements Orthofix may have made regarding its business operations and prospects.

The investigation focuses on Orthofix’s disclosures that an investigation conducted by independent outside legal counsel and directed and overseen by the Company’s independent directors that each of executive officers Keith Valentine, Chief Executive Officer, John Bostjancic, Chief Financial Officer, and Patrick Keran, Chief Legal Officer, engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company’s values and culture. Each of these executive officers was terminated for cause.